Ayala G - Search Results

1

The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.

Ayala G, Wang D, Wulf G, Frolov A, Li R, Sowadski J, Wheeler TM, Lu KP, Bao L. Ayala G, et al. Cancer Res. 2003 Oct 1;63(19):6244-51. Cancer Res. 2003. PMID: 14559810

2

Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.

Yang G, Ayala G, De Marzo A, Tian W, Frolov A, Wheeler TM, Thompson TC, Harper JW. Yang G, et al. Among authors: ayala g. Clin Cancer Res. 2002 Nov;8(11):3419-26. Clin Cancer Res. 2002. PMID: 12429629

3

Expression of neutral amino acid transporter ASCT2 in human prostate.

Li R, Younes M, Frolov A, Wheeler TM, Scardino P, Ohori M, Ayala G. Li R, et al. Among authors: ayala g. Anticancer Res. 2003 Jul-Aug;23(4):3413-8. Anticancer Res. 2003. PMID: 12926082

4

Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.

Tahir SA, Ren C, Timme TL, Gdor Y, Hoogeveen R, Morrisett JD, Frolov A, Ayala G, Wheeler TM, Thompson TC. Tahir SA, et al. Among authors: ayala g. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3653-9. Clin Cancer Res. 2003. PMID: 14506154

5

Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.

Ayala G, Tuxhorn JA, Wheeler TM, Frolov A, Scardino PT, Ohori M, Wheeler M, Spitler J, Rowley DR. Ayala G, et al. Clin Cancer Res. 2003 Oct 15;9(13):4792-801. Clin Cancer Res. 2003. PMID: 14581350

6

Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate.

Li R, Younes M, Wheeler TM, Scardino P, Ohori M, Frolov A, Ayala G. Li R, et al. Among authors: ayala g. Prostate. 2004 Feb 1;58(2):193-9. doi: 10.1002/pros.10321. Prostate. 2004. PMID: 14716745

7

High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.

Li R, Wheeler T, Dai H, Frolov A, Thompson T, Ayala G. Li R, et al. Among authors: ayala g. Am J Surg Pathol. 2004 Jul;28(7):928-34. doi: 10.1097/00000478-200407000-00013. Am J Surg Pathol. 2004. PMID: 15223964

8

High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.

Ayala G, Thompson T, Yang G, Frolov A, Li R, Scardino P, Ohori M, Wheeler T, Harper W. Ayala G, et al. Clin Cancer Res. 2004 Oct 1;10(19):6572-8. doi: 10.1158/1078-0432.CCR-04-0477. Clin Cancer Res. 2004. PMID: 15475446

9

Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort.

Tahir SA, Frolov A, Hayes TG, Mims MP, Miles BJ, Lerner SP, Wheeler TM, Ayala G, Thompson TC, Kadmon D. Tahir SA, et al. Among authors: ayala g. Clin Cancer Res. 2006 Aug 15;12(16):4872-5. doi: 10.1158/1078-0432.CCR-06-0417. Clin Cancer Res. 2006. PMID: 16914574

10

Neuroepithelial interactions in prostate cancer are enhanced in the presence ofprostatic stroma.

Cornell RJ, Rowley D, Wheeler T, Ali N, Ayala G. Cornell RJ, et al. Among authors: ayala g. Urology. 2003 Apr;61(4):870-5. doi: 10.1016/s0090-4295(02)02426-3. Urology. 2003. PMID: 12670591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

670 results

Search Page

Filters